We’re no longer posting on this account.
Want to stay up to date with all things Open Pharma?
Be sure to follow us on Bluesky (https://t.co/J4p35cBEQA) and LinkedIn (https://t.co/jTrIfeOAkE).
#OpenPharma#Bluesky#NewBeginnings
@ISMPP📢Medical publications professionals
We need your insights on the impact of content reuse restrictions and costs https://t.co/OBXKIBJGWI
The ISMPP twitter page is being utilized as a mechanism to post this survey only and does not necessarily represent the position of ISMPP
The #RegisteredReports (RR) peer review process avoids publication bias, helping clinicians to judge drug efficacy and safety accurately. In this post, @eturnermd1 and @chrisdc77 propose a way to harmonize RR with the FDA drug approval process. Read at: https://t.co/vfRUBxzT2x